BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease.
Public ClinicalTrials.gov record NCT02788513. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-centre, Double-blind, Parallel-group, Randomised Controlled Study to Investigate Efficacy and Safety of Orally Administered BI 425809 During a 12-week Treatment Period Compared to Placebo in Patients With Cognitive Impairment Due to Alzheimer's Disease.
Study identification
- NCT ID
- NCT02788513
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Boehringer Ingelheim
- Industry
- Enrollment
- 611 participants
Conditions and interventions
Conditions
Interventions
- BI 425809 dose 1 Drug
- BI 425809 dose 2 Drug
- BI 425809 dose 3 Drug
- BI 425809 dose 4 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 55 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 10, 2016
- Primary completion
- Sep 11, 2019
- Completion
- Oct 10, 2019
- Last update posted
- Nov 5, 2020
2016 – 2019
United States locations
- U.S. sites
- 17
- U.S. states
- 9
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Axiom Research LLC | Colton | California | 92324 | — |
| Alliance for Wellness | Long Beach | California | 90807 | — |
| Anderson Clinical Research | Redlands | California | 92374 | — |
| CITrials | Santa Ana | California | 92705 | — |
| MD Clinical | Hallandale | Florida | 33009 | — |
| Galiz Research | Miami | Florida | 33016 | — |
| Premier Clinical Research Institute | Miami | Florida | 33122 | — |
| Miami Jewish Health System | Miami | Florida | 33137 | — |
| Stedman Clinical Trials | Tampa | Florida | 33613 | — |
| Bioclinica Research | The Villages | Florida | 32162 | — |
| Neuro Trials Research Incorporated | Atlanta | Georgia | 30342 | — |
| Millennium Psychiatric Associates LLC | St Louis | Missouri | 63132 | — |
| ANI Neurology, PLLC, dba Alzheimer's Memory Center | Charlotte | North Carolina | 28270 | — |
| Tulsa Clinical Research, LLC | Tulsa | Oklahoma | 74104 | — |
| Northeastern Pennsylvania Memory and Alzheimer Center | Plains | Pennsylvania | 18705 | — |
| Roper St. Francis Healthcare | Charleston | South Carolina | 29401 | — |
| The Memory Clinic | Bennington | Vermont | 05201 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 78 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02788513, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 5, 2020 · Synced May 13, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02788513 live on ClinicalTrials.gov.